{"text": ["Novartis", "Cosentyx\u00ae", "receives", "FDA", "approval", "for", "the", "treatment", "of", "children", "and", "adolescents", "with", "enthesitis-related", "arthritis", "and", "psoriatic", "arthritis"], "created_at": "2021-12-22 23:00:00"}
{"text": ["FDA", "approves", "Novartis", "Leqvio\u00ae", "(inclisiran),", "first-in-class", "siRNA", "to", "lower", "cholesterol", "and", "keep", "it", "low", "with", "two", "doses", "a", "year"], "created_at": "2021-12-22 21:05:00"}
{"text": ["TBJ", "Plus:", "New", "CEO", "takes", "helm", "at", "Durham", "pharma;", "$1.5B", "deal", "has", "Triangle", "link;", "Big", "name", "change", "in", "Wilmington"], "created_at": "2021-12-22 17:13:15"}
{"text": ["Novartis", "to", "Buy", "Gene-Therapy", "Company", "Targeting", "Eye", "Condition"], "created_at": "2021-12-22 14:44:00"}
{"text": ["Novartis", "(NVS)", "to", "Buy", "Gyroscope,", "Submits", "Herceptin", "Biosimilar", "to", "EMA"], "created_at": "2021-12-22 14:12:02"}
{"text": ["Novartis", "Agrees", "to", "Acquire", "Gyroscope", "Therapeutics", "for", "$1.5", "Billion"], "created_at": "2021-12-22 13:09:00"}
{"text": ["Novartis", "to", "acquire", "Gyroscope", "Therapeutics,", "adding", "a", "one-time", "gene", "therapy", "that", "could", "transform", "care", "for", "geographic", "atrophy,", "a", "leading", "cause", "of", "blindness"], "created_at": "2021-12-22 07:00:00"}
{"text": ["Sandoz", "submits", "Marketing", "Authorization", "Application", "for", "proposed", "biosimilar", "trastuzumab", "to", "EMA"], "created_at": "2021-12-22 06:15:00"}
